2367 logo

Giant Biogene Holding SHSC:2367 Stock Report

Last Price

HK$51.35

Market Cap

HK$51.8b

7D

-0.6%

1Y

54.9%

Updated

21 Dec, 2024

Data

Company Financials +

Giant Biogene Holding Co., Ltd.

SHSC:2367 Stock Report

Market Cap: HK$51.8b

2367 Stock Overview

An investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. More details

2367 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth6/6
Past Performance6/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Giant Biogene Holding Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Giant Biogene Holding
Historical stock prices
Current Share PriceHK$51.35
52 Week HighHK$58.00
52 Week LowHK$28.75
Beta0.70
1 Month Change4.58%
3 Month Change32.35%
1 Year Change54.90%
3 Year Changen/a
5 Year Changen/a
Change since IPO57.76%

Recent News & Updates

Recent updates

Shareholder Returns

2367HK Personal ProductsHK Market
7D-0.6%-0.8%-0.5%
1Y54.9%19.3%19.9%

Return vs Industry: 2367 exceeded the Hong Kong Personal Products industry which returned 19.3% over the past year.

Return vs Market: 2367 exceeded the Hong Kong Market which returned 19.9% over the past year.

Price Volatility

Is 2367's price volatile compared to industry and market?
2367 volatility
2367 Average Weekly Movement8.2%
Personal Products Industry Average Movement7.1%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 2367 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 2367's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20001,512Jianya Yanwww.xajuzi.com

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands.

Giant Biogene Holding Co., Ltd. Fundamentals Summary

How do Giant Biogene Holding's earnings and revenue compare to its market cap?
2367 fundamental statistics
Market capHK$51.82b
Earnings (TTM)HK$1.88b
Revenue (TTM)HK$4.75b

27.5x

P/E Ratio

10.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2367 income statement (TTM)
RevenueCN¥4.46b
Cost of RevenueCN¥769.50m
Gross ProfitCN¥3.69b
Other ExpensesCN¥1.92b
EarningsCN¥1.77b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.75
Gross Margin82.74%
Net Profit Margin39.65%
Debt/Equity Ratio0%

How did 2367 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 01:17
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Giant Biogene Holding Co., Ltd. is covered by 28 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Junhao FanChina International Capital Corporation Limited
Zhuonan XuChina International Capital Corporation Limited
Joseph WongChina Merchants Securities (HK) Co., Ltd